EUROPE PROTEOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • EUROPE PROTEOMICS MARKET FORECAST 2019-2027

EUROPE PROTEOMICS MARKET FORECAST 2019-2027

The advancement in proteomic technologies, increase in R&D expenditure, technological advancements and the increasing use of proteomics information are essentially driving the market in the Europe regional market for proteomics. The Europe proteomics market is anticipated to generate revenue of $XX billion by 2027 and to grow at a CAGR of 14.49% between 2019 and 2027.

EUROPE PROTEOMICS MARKET FORECAST 2019-2027

Europe Proteomics Market by Application (Drug Discovery, Disease Diagnosis, Other Application) by Component (Reagents, Instruments, Services) by Geography.

Request free sample

The dynamic role of molecules to support life is documented since the initial stages of biological research. Proteomics takes one of the principal role to demonstrate the importance of these macromolecules in the living systems.

The advancement in proteomic technologies, increase in R&D expenditure, technological advancements and the increasing use of proteomics information are essentially driving the market in the Europe regional market for proteomics. The Europe proteomics market is anticipated to generate revenue of $XX billion by 2027 and to grow at a CAGR of 14.49% between 2019 and 2027.

The European proteomics market includes Germany, France, the UK, Italy, Spain and Rest of Europe. Europe has emerged as the second largest potential market for proteomics. As proteomic technologies are applicable in a wide range of clinical studies, the European Commission co-funded a project on proteomics by investing $XX million in 2015 for four years under the Horizon 2020 Program.

Proteomics research requires huge capital investment, which is supported by public funding institutions but results in a low outcome. The proteomics market is expected to witness significant growth. Therefore, the government and federal ministries across several countries in the region have invested in the industry to drive the market growth.

PerkinElmer, Inc., Danaher Corporation, Luminex Corp., Caprion Biosciences (acquired by GHO Capital), Horiba, Ltd., Bruker Corporation, GlaxoSmithKline, Qiagen N.V., Waters Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., LI-COR Inc., General Electric Company, Agilent Technologies, Inc., and Merck & Company Inc. are the major companies operating in the market which have been profiled extensively in the report.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REAGENTS ARE THE WIDELY USED PROTEOMICS COMPONENT
      • DISEASE DIAGNOSIS IS THE FASTEST GROWING APPLICATION
      • DRUG DISCOVERY AND DEVELOPMENT IS THE MAJORLY USED END-USER
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • ADVANCEMENT IN PROTEOMIC TECHNOLOGIES
      • INCREASE IN R&D EXPENDITURE
      • TECHNOLOGICAL ADVANCEMENTS
      • INCREASING USE OF PROTEOMICS INFORMATION
    • MARKET RESTRAINTS
      • HIGH COST OF INSTRUMENTS
    • MARKET OPPORTUNITIES
      • IDENTIFICATION OF NOVEL BIOMARKERS
      • WIDESPREAD USE OF MASS SPECTROMETER TO STUDY PROTEIN-PROTEIN INTERACTION
    • MARKET CHALLENGES
      • LACK OF SKILLED PROFESSIONALS
      • STRINGENT REGULATIONS
  1. MARKET BY APPLICATION
    • DRUG DISCOVERY
    • DISEASE DIAGNOSIS
    • OTHER APPLICATION
  2. MARKET BY COMPONENT
    • REAGENTS
    • INSTRUMENTS
    • SERVICES
  3. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • PROTEOMICS INDUSTRY ANALYSIS
    • APPLICATIONS OF PROTEOMIC IN DRUG DISCOVERY AND DEVELOPMENT
    • SCIENTIFIC INITIATIVES IN PROTEOMICS
    • PATENT ANALYSIS
    • OPPORTUNITY MATRIX
  4. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CAPRION BIOSCIENCES (ACQUIRED BY GHO CAPITAL)
      • DANAHER CORPORATION
      • GENERAL ELECTRIC COMPANY
      • GLAXOSMITHKLINE
      • HORIBA, LTD.
      • LI-COR INC
      • LUMINEX CORP.
      • MERCK & COMPANY INC.
      • PERKINELMER, INC.
      • QIAGEN N.V.
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

LIST OF TABLES

TABLE 1        EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)

TABLE 2        EUROPE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 3        EUROPE DRUG DISCOVERY MARKET 2019-2027 ($ MILLION)

TABLE 4        EUROPE DISEASE DIAGNOSIS MARKET 2019-2027 ($ MILLION)

TABLE 5        EUROPE OTHER APPLICATION MARKET 2019-2027 ($ MILLION)

TABLE 6        EUROPE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 7        EUROPE REAGENTS MARKET 2019-2027 ($ MILLION)

TABLE 8        EUROPE INSTRUMENTS MARKET 2019-2027 ($ MILLION)

TABLE 9        GENERAL WORKFLOW OF MASS SPECTROMETRY (MS)

TABLE 10      EUROPE SERVICES MARKET 2019-2027 ($ MILLION)

TABLE 11      STATUS OF THE MAJOR PROTEOMICS INDUSTRIES

TABLE 12      ARRAY-RELATED PROTEOMICS PATENTS 2015–2018 (%)

TABLE 13      LOC-RELATED PROTEOMICS PATENTS 2015-2018 (%)

TABLE 14      MASS SPECTROMETRY-RELATED PROTEOMICS PATENTS 2015-2018(%)

TABLE 15      EUROPE PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 16      GERMANY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 17      GERMANY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 18      FRANCE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 19      FRANCE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 20      THE UNITED KINGDOM PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 21      THE UNITED KINGDOM PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 22      ITALY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 23      ITALY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 24      SPAIN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 25      SPAIN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 26      PROTEOMICS COMPANY MARKET POSITION ANALYSIS 2027

LIST OF FIGURES

FIGURE 1      EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 2      EUROPE PROTEOMICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 3      EUROPE PROTEOMICS MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)

FIGURE 4      EUROPE PROTEOMICS MARKET BY DISEASE DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 5      EUROPE PROTEOMICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)

FIGURE 6      EUROPE PROTEOMICS MARKET SHARE BY COMPONENT 2018 & 2027 (%)

FIGURE 7      EUROPE PROTEOMICS MARKET BY REAGENTS 2019-2027 ($ MILLION)

FIGURE 8      EUROPE PROTEOMICS MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)

FIGURE 9      EUROPE PROTEOMICS MARKET BY SERVICES 2019-2027 ($ MILLION)

FIGURE 10   PORTER’S FIVE FORCE MODEL

FIGURE 11   GERMANY PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 12   FRANCE PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 13   THE UNITED KINGDOM PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 14   ITALY PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 15   SPAIN PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 16   REST OF EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
  1. MARKET BY APPLICATION
    • DRUG DISCOVERY
    • DISEASE DIAGNOSIS
    • OTHER APPLICATION
  2. MARKET BY COMPONENT
    • REAGENTS
    • INSTRUMENTS
    • SERVICES

 

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now